ArticlePilot and feasibility studies2023

Evaluating the feasibility of prolonged-release buprenorphine formulations as an alternative to daily opioid agonist therapy regardless of prior treatment adherence: a pilot study.

Bernadette Hard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.